American Healthcare Reit (AHR) Q4 FY2023 earnings

American Healthcare Reit, Inc. (AHR) files the full year and not its fourth quarter on its own, and for Q4 FY2023, the quarter ended 31 December 2023, the year and the three quarters before it carry revenue under different lines of the filing, so the difference would not be a quarter's revenue and it is left blank. The other lines of the quarter are below, and the year is on the company's page, from the 10-K filed with the SEC on 27 February 2026.

Revenue

Net income-$27 million

Diluted EPS$-0.41

QuarterQ4 FY2023ended 31 December 2023

The quarter, against the one before and a year earlier

Line	Q4 FY2023	Q3 FY2023	A year earlier	Change on the year
Revenue	n/a	416	n/a	n/a
Cost of revenue	385	375	n/a	n/a
Gross profit	n/a	41.6	n/a	n/a
Gross margin	n/a	10.0%	n/a
Operating income	84.5	75.1	n/a	n/a
Operating margin	n/a	18.0%	n/a
Interest expense	41.2	42.0	n/a	n/a
Pre-tax income	-31.1	-6.2	n/a	n/a
Income tax	-0.1	0.3	n/a	n/a
Net income	-27.4	-6.0	n/a	n/a
Net margin	n/a	-1.4%	n/a
Diluted EPS	-$0.41	-$0.09	n/a	n/a

$ million except per share.

Fourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

Line	Q4 FY2023	Q3 FY2023	A year earlier	Change on the year
Operating cash flow	25.8	29.1	n/a	n/a
Cash from investing	-11.3	11.0	n/a	n/a
Cash from financing	-5.9	-51.6	n/a	n/a
Depreciation and amortisation	44.0	49.3	n/a	n/a
Share-based compensation	1.2	1.6	n/a	n/a
Buybacks	0.3	0.0	n/a	n/a
Dividends paid	16.6	16.6	n/a	n/a
Dividend per share	n/a	$0.25	n/a	n/a
Diluted shares, weighted	66m	66m	n/a	n/a
Shares outstanding at period end	188m	n/a	n/a	n/a

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

Line	Q4 FY2023	Q3 FY2023	A year earlier	Change on the year
Shareholders' equity	1,270	1,314	n/a	n/a
Non-controlling interest	155	159	n/a	n/a
Debt	1,326	1,243	n/a	n/a
Other liabilities	1,826	1,872	n/a	n/a
Total liabilities and equity	4,578	4,589	n/a	n/a
Goodwill	235	235	n/a	n/a
Intangible assets	180	197	n/a	n/a
Securities held for sale or to maturity	86.9	85.9	n/a	n/a
Cash and equivalents	43.4	35.2	n/a	n/a
Inventory	19.5	22.0	n/a	n/a
Other assets	4,013	4,014	n/a	n/a
Total assets	4,578	4,589	n/a	n/a

Quarterly results, the last 12 quarters

	Q3 FY2023	Q4 FY2023 *	Q1 FY2024	Q2 FY2024	Q3 FY2024	Q4 FY2024 *	Q1 FY2025	Q2 FY2025	Q3 FY2025	Q4 FY2025 *	Q1 FY2026	Q2 FY2026
Revenue	416	n/a	500	505	524	543	541	543	573	604	651	674
Cost of revenue	375	385	404	403	417	431	432	426	455	480	512	525
Gross profit	41.6	n/a	95.9	102	107	112	108	116	118	124	139	149
Gross margin	10%	n/a	19%	20%	20%	21%	20%	21%	21%	20%	21%	22%
Operating income	75.1	84.5	82.2	88.7	93.5	99.1	94.5	103	106	112	126	137
Operating margin	18%	n/a	16%	18%	18%	18%	17%	19%	18%	18%	19%	20%
Interest expense	42.0	41.2	36.4	30.6	30.4	30.3	22.9	22.6	20.4	19.8	18.8	18.6
Pre-tax income	-6.2	-31.1	-2.7	3.6	-2.8	-31.9	-6.2	10.8	35.5	8.5	23.5	31.0
Tax rate	n/a	n/a	n/a	19%	n/a	n/a	n/a	7%	-59%	-28%	-2%	-0%
Net income	-6.0	-27.4	-3.9	2.0	-4.1	-31.8	-6.8	9.9	55.9	10.8	23.7	30.6
Net margin	-1%	n/a	-1%	0%	-1%	-6%	-1%	2%	10%	2%	4%	5%
Diluted EPS	-$0.09	-$0.41	-$0.04	$0.01	-$0.03	-$0.23	-$0.04	$0.06	$0.33	$0.06	$0.13	$0.16
Operating cash flow	29.1	25.8	-6.0	59.4	63.1	59.5	60.6	71.5	107	55.2	81.1	119
Buybacks	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	n/a	n/a
Dividends paid	16.6	16.6	16.6	33.0	33.0	38.3	39.5	39.9	41.2	42.9	46.8	47.6
Shares outstanding	n/a	188m	n/a	169m	177m	188m	159m	169m	177m	186m	190m	195m
Filing	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q

Each quarter as filed, linked to its filing.

* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS and diluted share count are from the company's results press release for that quarter, used where the release gives the same revenue and net income as the table. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-K for the period ended 31 December 2023, filed 27 February 2026, accession 0001193125-26-082692: the filing on EDGAR. All of American Healthcare Reit, Inc.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install